Pages that link to "Q38980049"
Jump to navigation
Jump to search
The following pages link to Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum (Q38980049):
Displaying 50 items.
- Occurrence of pfatpase6 Single Nucleotide Polymorphisms Associated with Artemisinin Resistance among Field Isolates of Plasmodium falciparum in North-Eastern Tanzania (Q21284494) (← links)
- Current perspectives on the mechanism of action of artemisinins (Q22061943) (← links)
- Molecular characterisation of drug-resistant Plasmodium falciparum from Thailand (Q24799200) (← links)
- The relationship of physico-chemical properties and structure to the differential antiplasmodial activity of the cinchona alkaloids (Q24801973) (← links)
- Antimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR Network (Q26799713) (← links)
- The interplay between drug resistance and fitness in malaria parasites (Q26998596) (← links)
- In Vitro Resistance Selections for Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors Give Mutants with Multiple Point Mutations in the Drug-binding Site and Altered Growth (Q27683596) (← links)
- Disruption of a Plasmodium falciparum Multidrug Resistance-associated Protein (PfMRP) Alters Its Fitness and Transport of Antimalarial Drugs and Glutathione (Q27861935) (← links)
- Gold mining areas in Suriname: reservoirs of malaria resistance? (Q28128631) (← links)
- Sulfadoxine-pyrimethamine-based combinations for malaria: a randomised blinded trial to compare efficacy, safety and selection of resistance in Malawi (Q33319559) (← links)
- Assessment of copy number variation in genes related to drug resistance in Plasmodium vivax and Plasmodium falciparum isolates from the Brazilian Amazon and a systematic review of the literature (Q33577218) (← links)
- Molecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria (Q33721915) (← links)
- Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum (Q33876651) (← links)
- Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania (Q33905089) (← links)
- Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia (Q33938016) (← links)
- Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan children (Q33947834) (← links)
- Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum (Q33981743) (← links)
- Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations (Q34198094) (← links)
- Altered temporal response of malaria parasites determines differential sensitivity to artemisinin (Q34329125) (← links)
- Assessment of Plasmodium falciparum PfMDR1 transport rates using Fluo-4. (Q34336883) (← links)
- Emerging artemisinin resistance in the border areas of Thailand (Q34343530) (← links)
- Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2 ATPase), tctp, mdr1, and cg10. (Q34352253) (← links)
- Biochemical and molecular mechanisms of drug resistance in parasites (Q34434811) (← links)
- Medical need, scientific opportunity and the drive for antimalarial drugs (Q34521004) (← links)
- Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs (Q34552816) (← links)
- Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan (Q34569732) (← links)
- Resistance to antiparasitic drugs: the role of molecular diagnosis. (Q34863059) (← links)
- Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin (Q34597550) (← links)
- Genetic diversity of Plasmodium falciparum: asexual stages. (Q34631509) (← links)
- Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic (Q34648820) (← links)
- The impact of multiple drug resistance (MDR) proteins on chemotherapy and drug discovery. (Q34701048) (← links)
- Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum (Q34767732) (← links)
- Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal (Q34826216) (← links)
- Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial (Q34910448) (← links)
- Multiple genetic backgrounds of the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184F mutation in Cambodia (Q34986023) (← links)
- Artemisinin: mechanisms of action, resistance and toxicity (Q34999485) (← links)
- Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria (Q35112348) (← links)
- Prolonged Selection of pfmdr1 Polymorphisms After Treatment of Falciparum Malaria With Artemether-Lumefantrine in Uganda (Q35188480) (← links)
- Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy (Q35356543) (← links)
- Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine (Q35364589) (← links)
- Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy (Q35576130) (← links)
- Molecular markers for drug resistance in malaria: use in treatment, diagnosis and epidemiology (Q35587122) (← links)
- Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro. (Q35636034) (← links)
- Polymorphisms of the pfmdr1 but not the pfnhe-1 gene is associated with in vitro quinine sensitivity in Thai isolates of Plasmodium falciparum (Q35782169) (← links)
- Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya (Q35849636) (← links)
- Distribution of drug resistance genotypes in Plasmodium falciparum in an area of limited parasite diversity in Saudi Arabia (Q35910532) (← links)
- Amino acid efflux by asexual blood-stage Plasmodium falciparum and its utility in interrogating the kinetics of hemoglobin endocytosis and catabolism in vivo (Q36055139) (← links)
- Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal (Q36316217) (← links)
- In vitro-reduced susceptibility to artemether in P. falciparum and its association with polymorphisms on transporter genes (Q36376217) (← links)
- The detection of pfcrt and pfmdr1 point mutations as molecular markers of chloroquine drug resistance, Pahang, Malaysia (Q36383936) (← links)